Skip to content

Opening book details…

About this Medicine article

Significant Antitumor Activity of E-3810, a Novel FGFR and VEGFR Inhibitor, in Patients With FGFR1 Amplified Breast Cancer by Dienstmann, R. ;Andre, F. ;Soria, J. ;Tabernero, J. ;De Braud, F.G.M. ;Cereda, R. ;Bahleda, R. ;Hollebecque, A. ;Delmonte, A. ;Camboni, M.G. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Dienstmann, R. ;Andre, F. ;Soria, J. ;Tabernero, J. ;De Braud, F.G.M. ;Cereda, R. ;Bahleda, R. ;Hollebecque, A. ;Delmonte, A. ;Camboni, M.G.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2012
Field
Medicine (Health Sciences)

More by Dienstmann, R. ;Andre, F. ;Soria, J. ;Tabernero, J. ;De Braud, F.G.M. ;Cereda, R. ;Bahleda, R. ;Hollebecque, A. ;Delmonte, A. ;Camboni, M.G.

Browse all works by Dienstmann, R. ;Andre, F. ;Soria, J. ;Tabernero, J. ;De Braud, F.G.M. ;Cereda, R. ;Bahleda, R. ;Hollebecque, A. ;Delmonte, A. ;Camboni, M.G.